Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...

公司管理层在第二季度财报会议中强调，医生对大量患者处方该药物，这表明医疗界对其信心不断提升。此外，约60%的患者享有商业保险覆盖，40%由政府医保计划覆盖，且超过90%的患者无需支付自付费用，这些因素共同促成了药物的成功。

Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts. On July 14, UBS reiterated ...

The First Trust Health Care AlphaDEX ETF (FXH) was launched on May 8, 2007, and is a passively managed exchange traded fund ...

Pharma stock under pressure as Trump plans to hike pharmaceutical tariffs up to 250%, aiming to boost U.S. production. Read more here.